John P Clancy, MD | Negative interactions between Beta2 AR agonists and F508del CFTR modulators

March 21, 2017 by wpc2m@virginia.edu   |   Leave a Comment

Date: Friday April 14, 2017
Time: 11:45 AM until 1:00 PM
Location: Battle Bldg Quayle Learning Center

ClancyPicture

John P. Clancy, MD

Cincinnati Children’s Hospital, Pediatrics

Pulmonary Division

Objective 1 – To understand the biology of different classes of CFTR mutations, and how CFTR modulators restore CFTR function

Objective 2 – To appreciate the regulation of CFTR by surface G protein coupled receptors including b2 adrenergic receptors

Objective 3 – to describe how chronic activation of b2 adrenergic receptors interferes with F508del CFTR modulation by lumacaftor


Contact cline@virginia.edu for more information

 

Comments

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.